Association of the mitochondrial 8344 MERRF mutation with maternally inherited spinocerebellar degeneration and Leigh disease

Neurology

Volumn 46, Issue 1, 1996, Pages 219-222

  Howell, N ^a,e   Kubacka, I ^a   Smith, R ^b,c   Frerman, F ^c   Parks, J K ^d   Parker Jr , W D ^d  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c Children's Hospital Colorado   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

^e University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA; NUCLEOTIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DEGENERATIVE DISEASE; DISEASE TRANSMISSION; DNA SEQUENCE; ELECTRON TRANSPORT; FEMALE; GENETIC ANALYSIS; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; INFANT; LEIGH DISEASE; MALE; MERRF SYNDROME; MULTIGENE FAMILY; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY CHAIN; SPINOCEREBELLAR DEGENERATION;

EID: 0029977170     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.46.1.219     Document Type: Article

References (16)

1. Matthews PM, Andermann F, Silver K, Karpati G, Arnold DL. Proton MR spectroscopic characterization of differences in regional brain metabolic abnormalities in mitochondrial encephalomyopathies. Neurology 1993;43:2484-2490.
2. Sparaco M, Bonilla E, DiMauro S, Powers JM. Neuropathology of mitochondrial encephalomyopathies due to mitochondrial DNA defects. J Neuropathol Exp Neurol 1993;52:1-10.
3. Brown MD, Wallace DC. Molecular basis of mitochondrial DNA disease. J Bioenerg Biomembr 1994;26:273-289.
4. Guggenheim MA, Stumpf DA. Familial metabolic disease with clinicopathological findings of both Leigh's disease and adult-type spinocerebellar degeneration. Ann Neurol 1977;2:264-265.
5. Howell N, Kubacka I, Xu M, McCullough DA. Leber hereditary optic neuropathy: involvement of the mitochondrial ND1 gene and evidence for an intragenic suppressor mutation. Am J Hum Genet 1991;48:935-942.
6. Parker WD Jr, Frerman F, Haas R, Parks JK. Myxothiazol resistance in human mitochondria. Biochim Biophys Acta 1988;936133-138.
7. (8344) mutation and the syndrome of myoclonic epilepsy with ragged red fibres (MERRF): relationship of clinical phenotype to proportion of mutant mitochondrial DNA. Brain 1993;116:617-632.
8. Silvestri G, Ciafaloni E, Santorelli FM, et al. Clinical features associated with the A > G transition at nucleotide 8344 of mtDNA ("MERRF mutation"). Neurology 1993;43:1200-1206.
9. i sites and the heme prosthetic groups in ubiquinol-cytochrome c oxidoreductase. Biochem 1993;32:11162-11172.
10. Sweeney MG, Hammans SR, Duchen LW, et al. Mitochondrial DNA mutation underlying Leigh's syndrome: clinical, pathological, biochemical, and genetic studies of a patient presenting with progressive myoclonic epilepsy. J Neurol Sci 1994; 121:57-65.
11. Greenwood RS, DeVivo DC, Nelson JS, et al. An autosomal dominant form of necrotizing encephalomyelopathy resembling a spinocerebellar degeneration. Trans Am Neurol Assoc 1975;100:47-51.
12. Calabresi PA, Silvestri G, DiMauro S, Griggs RC. Ekbom's syndrome: lipomas, ataxia, and neuropathy with MERRF. Muscle Nerve 1994;17:943-945.
13. Meunier B, Colson-Corbisier A-M, Lemesle-Meunier D. Nuclearly inherited diuron-resistant mutations conferring a deficiency in the NADH- or succinate - ubiquinone oxidoreductase activity in Saccharomyces cerevisiae. Eur J Biochem 1989; 184:651-656.
14. Berkovic SF, Carpenter S, Evans A, et al. Myoclonus epilepsy and ragged-red fibres (MERRF). 1. A clinical, pathological, biochemical, magnetic resonance spectrographic and positron emission tomographic study. Brain 1989;112:1231-1260.
15. Cavanagh JB, Harding BN. Pathogenic factors underlying the lesions in Leigh's disease: Tissue responses to cellular energy deprivation and their clinico-pathological consequences. Brain 1994;117:1357-1376.
16. lys(8344) (MERRF) mutation. J Neurol 1994;241:335-340.